Europe Dialysis Equipment Market Outlook (2021-2031)

The European dialysis equipment market is projected to grow significantly, reaching approximately USD 5,568.50 million by 2031, up from USD 3,798.80 million in 2024. The market is expected to achieve a compound annual growth rate (CAGR) of 5.62% from 2025 to 2031.

Executive Summary and Market Analysis:

The dialysis equipment market in Europe is experiencing robust growth, primarily due to the increasing prevalence of kidney disease. According to the European Renal Association, over 546,000 individuals are currently receiving renal replacement therapy (RRT) for end-stage renal disease (ESRD), with marked differences in the incidence across various countries.

The incidence of dialysis varies considerably; for instance, Portugal reports some of the highest prevalence rates, while Ukraine has significantly lower numbers. The rising burden of chronic kidney disease (CKD) is largely attributed to aging populations, diabetes, and hypertension—three major risk factors for kidney disease. Furthermore, disparities in access to kidney replacement therapy (KRT) have led to variations in treatment availability across different regions in Europe.

Market Segmentation

Analysis:

The dialysis equipment market can be segmented into products, applications, and end users:

By Product: The market is divided into hemodialysis equipment, peritoneal dialysis equipment, concentrates and solutions, catheters and tubing, and other products. In 2024, the hemodialysis equipment segment held a dominant position in the market.
By Application: The market is segmented into hemodialysis and peritoneal dialysis, with hemodialysis holding the largest share in 2024.
By End User: The market is categorized into in-center dialysis settings and home care settings, with in-center dialysis settings having the largest share in 2024.

Market Outlook:

The European dialysis equipment market comprises countries such as Belgium, the Netherlands, Luxembourg, Germany, France, Italy, the Russian Federation, Spain, Switzerland, Turkey, Poland, Sweden, Austria, the United Kingdom, Denmark, Ukraine, Romania, Greece, Portugal, Norway, and Finland. This market is a significant and mature segment of the global healthcare industry, projected to continue its growth steadily.

Growth is anticipated for two primary reasons: the increasing prevalence of CKD and ESRD, notably among elderly populations with high incidences of diabetes and hypertension, and the established universal healthcare systems in Europe that allocate a significant portion of healthcare resources to dialysis treatment. Additionally, there is a growing focus on enhancing the quality of life for patients and reducing patient care costs, which has led to a shift toward home-based dialysis solutions.

Major international companies are driving innovation in this market. Notably, Fresenius Medical Care, headquartered in Germany, has been expanding home hemodialysis programs across Germany and the UK. At the same time, Braun Avitum launched their Dialog iQ next-generation hemodialysis machine in Italy and Spain in February 2025.

Country Insights

The European dialysis equipment market is categorized by region, which includes Belgium, the Netherlands, Luxembourg, Germany, France, Italy, the Russian Federation, Spain, Switzerland, Turkiye, Poland, Sweden, Austria, the United Kingdom, Denmark, Ukraine, Romania, Greece, Portugal, Norway, and Finland. In 2024, Germany held the largest market share.

The dialysis equipment market in Germany is significantly influenced by demographic trends and a high prevalence of chronic illnesses that can lead to kidney failure. The population is aging rapidly, with a higher-than-average proportion of individuals over the age of 65. This trend is expected to continue over the next decade, with a median age projected to be over 45 years by 2025, according to Statistics Germany and Worldometer data. This demographic shift results in a larger pool of individuals affected by chronic kidney disease (CKD), alongside other major chronic conditions such as diabetes and hypertension.

The German Health Report on Diabetes 2025, published in November 2024, estimated that over 9 million people in Germany are affected by Type 2 diabetes (including undiagnosed cases), along with a significant number of Type 1 diabetes patients. Both diabetes and hypertension are leading contributors to CKD, which can progress to end-stage renal disease (ESRD). In September 2024, the German Society of Nephrology (DGfN) estimated that more than 9 million people in Germany are affected by CKD, with over 100,000 patients requiring permanent dialysis.

The Versorgungsatlas report from October 2024 indicated a noticeable increase in the prevalence of diabetic kidney disease among patients aged over 40. The large number of patients requiring renal replacement therapy (RRT) creates a continuous demand for dialysis equipment, such as hemodialysis machines, dialyzers, and associated consumables. These are primarily sourced from dialysis centers and hospitals, with some patients utilizing home-based therapies. The ongoing management of this substantial patient population necessitates continuous investment in and the provision of dialysis technology throughout the German healthcare system.

Italy, characterized by one of the oldest populations in Europe, reached a median age of 46.6 years by December 31, 2023, with individuals over 65 making up 24.3% of the population, an increase from 24% in 2022, according to ISTAT data released in December 2024. This aging trend significantly contributes to the burden of CKD. Additionally, diabetes and hypertension are prevalent health issues in Italy, further increasing the need for renal replacement therapy.

Europe Dialysis Equipment Market Company Profiles

Key players in the market include Fresenius Medical Care AG & Co KGaA, Baxter International Inc., B. Braun SE, Nipro Corp, Medtronic Plc, Nikkiso Co Ltd, Teleflex Inc., Asahi Kasei Medical Co., Ltd., Terumo Corp, and DaVita Inc. These companies employ strategies such as expansion, product innovation, and mergers and acquisitions to remain competitive and offer innovative products to consumers. Show more